In the present study, we demonstrated that decreased MAD2L1 expression in MKN45 cells contributes to decreased PTX sensitivity in vitro and we confirmed the relationship between low MAD2L1 expression and the negative effects of PTX on recurrent GC by immunostaining. The gene discussed is MAD2L1; the disease is gastric cancer.